Investing.com - Sensei Biotherapeutics reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Sensei Biotherapeutics announced earnings per share of $-0.44 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.40 on revenue of $0.
Sensei Biotherapeutics 's are down 41.36% and is trading at $1.39 , still down 86.24% from its 52 week high of $10.10 set on Monday, November 15, 2021.
Sensei Biotherapeutics shares lost 0.71% to trade at $1.39 in intra-day trade the report.
Sensei Biotherapeutics follows other major Healthcare sector earnings this month
Sensei Biotherapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar